Skip to content

New study from Intuitive Biosciences uses CSA assays to monitor candidate vaccine efficacy in nonhuman primate model for SARS-CoV-2.

“A recombinant protein SARS-CoV-2 candidate vaccine elicits high-titer neutralizing antibodies in macaques.” Gary Baisa, David Rancour, Keith Mansfield, Monika Burns, Lori Martin, Daise Cunha, Jessica Fischer,  Frauke Muecksch, Theodora Hatziioannou, Paul D. Bieniasz, Fritz Schomburg, Kimberly Luke* *corresponding author: Vaccines that generate robust and long-lived protective immunity against SARS-CoV-2 infection are urgently required. We assessed the potential of vaccine candidates based…